Market Research Life Sciences Market Research Pharmaceuticals Market Research Therapeutic Area Market Research Cardiovascular Market Research

Global Stroke Market - Industry Trends and Forecast to 2030

Best Price Guarantee Length Publisher Published Date SKU
from $4,800 764 Pages Data Bridge Market Research October, 2023 DAABD18360528
Best Price Guarantee
Price from $4,800
Length 764 Pages
Publisher Data Bridge Market Research
Published Date October, 2023
SKU DAABD18360528

Global Stroke Market - Industry Trends and Forecast to 2030


Global Stroke market is projected to register a CAGR of 7.5% in the forecast period of 2023 to 2030. The new market report contains data for historic year 2021, the base year of calculation is 2022 and the forecast period is 2023 to 2030.
Market Segmentation
Global Stroke Market, By Type (Ischemic Stroke, Transient Ischemic Attack (TIA) and Hemorrhage Stroke), Diagnosis (Imaging Test, Blood Test, Echocardiogram, Lumbar Puncture, and Other), Treatment (Medication, Other Therapy, and Surgery), Gender (Female and Male), End-User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, Laboratories and Others), Distribution Channel (Direct Tender, Retail Sales And Online Sales) Country (U.S., Canada, Mexico, Germany, U.K., France, Russia, Italy, Spain, Turkey, Poland, Belgium, Netherlands, Switzerland, Denmark, Sweden, Norway, Finland, Rest of Europe, China, Japan, India, Australia, South Korea, New Zealand, Singapore, Thailand, Philippines, Malaysia, Indonesia, Vietnam, Taiwan, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, Saudi Arabia, UAE, South Africa, Egypt, Qatar, Kuwait, Oman, Bahrain and Rest of Middle East And Africa) – Industry trends and forecast to 2030
Overview of Global Stroke Market Dynamics

Drivers
• Rising incidences of stroke
• Increasing number of patients with hypertension and coronary heart diseases

Restraints

• High cost associated with treatment of stroke
• Side-effects associated with medication

Opportunities

• Expansion of telemedicine and remote monitoring
• Innovative therapies in pipeline for stroke treatment

Market Players
Some of the major market players operating in the global stroke market are:
• Bristol-Myers Squibb Company
• Boehringer Ingelheim International GmbH.
• F. Hoffmann-La Roche Ltd
• DAIICHI SANKYO COMPANY, LIMITED.
• Sanofi
• Johnson & Johnson Services, Inc.
• Bayer AG
• Sandoz AG
• Pfizer Inc.
• Medtronic
• Abbott
• Viatris Inc.
• AstraZeneca
• Penumbra, Inc.
• GLENMARK PHARMACEUTICALS LTD
• Fresenius Kabi USA
• Teva Pharmaceuticals USA, Inc.
• Lupin
• Amneal Pharmaceuticals LLC.
• Oxford Laboratories Pvt. Ltd.


1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of The Global Stroke Market
1.4 Limitations
1.5 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Dbmr Tripod Data Validation Model
2.6 Multivariate Modelling
2.7 Type Lifeline Curve
2.8 Primary Interviews With Key Opinion Leaders
2.9 Dbmr Market Position Grid
2.10 Market Application Coverage Grid
2.11 Vendor Share Analysis
2.12 Secondary Sources
2.13 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Pestel's Model
4.2 Porter's 5 Forces
5 Epidemiology
6 Global Stroke Market, Regulatory Framework
6.1 Regulation In U.S.
6.2 Regulation In Europe
6.3 Regulation In China
6.4 Regulation In Japan
6.5 Regulation In South Africa 7 Market Overview
7.1 Drivers
7.1.1 Rising Incidences Of Stroke
7.1.2 Increasing Number Of Patients With Hypertension And Coronary Heart Diseases
7.1.3 Increasing Diabetic And Obese Population
7.1.4 Advancements In Medical Technology For Stroke Treatment
7.2 Restraints
7.2.1 High Cost Associated With Treatment Of Stroke
7.2.2 Side-effects Associated With Medication
7.3 Opportunities
7.3.1 Expansion Of Telemedicine And Remote Monitoring
7.3.2 Innovative Therapies In Pipeline For Stroke Treatment
7.4 Challenges
7.4.1 Inaccurate Diagnosis Of Strokes S
7.4.2 Complications In Managing Stroke In Patients With Multiple Chronic Conditions
8 Global Stroke Market, By Type
8.1 Overview
8.2 Ischemic Stroke
8.2.1 Thrombotic (Cerebral Thrombosis)
8.2.2 Embolic (Cerebral Embolism)
8.3 Hemorrhagic Stroke
8.3.1 Subarachnoid Hemorrhage
8.3.2 Intracerebral Hemorrhage
8.4 Transient Ischemic Attack (Tia)
9 Global Stroke Market, By Treatment
9.1 Overview
9.2 Medication
9.2.1 By Class
9.2.1.1 Blood Pressure Medicines
9.2.1.1.1 Angiotensin-converting Enzyme (Ace) Inhibitors
9.2.1.1.1.1 Ramipril
9.2.1.1.1.2 Lisinopril
9.2.1.1.1.3 Enalapril
9.2.1.1.1.4 Perindopril
9.2.1.1.1.5 Other 9.2.1.1.2 Diuretics
9.2.1.1.2.1 Indapamide
9.2.1.1.2.2 Bendroflumethiazide
9.2.1.1.2.3 Spironolactone
9.2.1.1.2.4 Amiloride
9.2.1.1.2.5 Other
9.2.1.1.3 Calcium Channel Blockers
9.2.1.1.3.1 Amlodipine
9.2.1.1.3.2 Nifedipine
9.2.1.1.3.3 Verapamil
9.2.1.1.3.4 Nicardipine
9.2.1.1.3.5 Felodipine
9.2.1.1.3.6 Nimodipine
9.2.1.1.3.7 Other
9.2.1.1.4 Beta Blockers
9.2.1.1.4.1 Atenolol
9.2.1.1.4.2 Bisoprolol
9.2.1.1.4.3 Labetolol
9.2.1.1.4.4 Other
9.2.1.1.5 Alpha Blockers
9.2.1.1.5.1 Doxazosin
9.2.1.1.5.2 Other
9.2.1.1.6 Others
9.2.1.1 Antiplatelet Drugs
9.2.1.1.1 Aspirin
9.2.1.1.2 Clopidogrel
9.2.1.1.3 Dipyridamole
9.2.1.1.4 Ticlopidine
9.2.1.1.5 Others
9.2.1.2 Anticoagulants
9.2.1.2.1 Warfarin
9.2.1.2.2 Apixaban
9.2.1.2.3 Dabigatran
9.2.1.2.4 Heparin
9.2.1.2.5 Rivaroxaban
9.2.1.2.6 Others
9.2.1.3 Tissue Plasminogen Activator (Tpa)
9.2.1.3.1 Alteplase
9.2.1.3.2 Tenecteplase
9.2.1.3.3 Reteplase
9.2.1.3.4 Anistreplase
9.2.1.3.5 Others
9.2.1.4 Statins
9.2.1.4.1 Atorvastatin
9.2.1.4.2 Simvastatin
9.2.1.4.3 Lovastatin
9.2.1.4.4 Rosuvastatin
9.2.1.4.5 Fluvastatin
9.2.1.4.6 Pravastatin
9.2.1.4.7 Pitavastatin
9.2.1.4.8 Others
9.2.1.5 Vitamin K
9.2.1.6 Supportive Medication
9.2.1.6.1 Nutritional Supplements
9.2.1.6.2 Antipyretics
9.2.1.6.3 Others
9.2.2 By Drug Type
9.2.2.1 Generics
9.2.2.2 Branded
9.2.2.2.1 Eliquis
9.2.2.2.2 Pradaxa
9.2.2.2.3 Activase
9.2.2.2.4 Aspirin
9.2.2.2.5 Plavix
9.2.2.2.6 Aggrenox
9.2.2.2.7 Others
9.2.3 By Route Of Administration
9.2.3.1 Oral
9.2.3.1.1 Tablet
9.2.3.1.2 Capsules
9.2.3.1.3 Others
9.2.3.2 Parenteral
9.2.3.2.1 Intravenous
9.2.3.2.2 Subcutaneous
9.2.3.3 Others
9.2.4 By Mode Of Purchase
9.2.4.1 Prescription
9.2.4.2 Over The Counter (Otc)
9.2.5 By Therpay Type
9.2.5.1 Combination Therapy
9.2.5.2 Monotherapy
9.3 Surgery
9.3.1 Embolic Coils
9.3.2 Aspiration Catheters
9.3.3 Stent Retriever
9.3.4 Surgical Clipping
9.3.5 Others
9.4 Other Therapy
9.4.1 Physical Therapy
9.4.2 Occupational Therapy
9.4.3 Speech Therapy
9.4.4 Others
10 Global Stroke Market, By Diagnosis
10.1 Overview
10.2 Imaging Test
10.2.1 Computerized Tomography (Ct) Scan
10.2.2 Magnetic Resonance Imaging (Mri)
10.2.3 Carotid Ultrasound
10.2.4 Cerebral Angiogram
10.3 Blood Test
10.4 Echocardiogram
10.5 Lumbar Puncture
10.6 Others
11 Global Stroke Market, By Gender
11.1 Overview
11.2 Female
11.3 Male
12 Global Stroke Market, By End User
12.1 Overview
12.2 Hospitals & Clinics
12.3 Specialty Clinics
12.4 Ambulatory Surgical Center
12.5 Homecare
12.6 Laboratories
12.7 Others 13 Global Stroke Market, By Distribution Channel
13.1 Overview
13.2 Direct
13.3 Retail
13.4 Online
14 Global Stroke Market, By Region
14.1 Overview
14.2 North America
14.2.1 U.S.
14.2.2 Canada
14.2.3 Mexico
14.3 Europe
14.3.1 Germany
14.3.2 U.K.
14.3.3 France
14.3.4 Russia
14.3.5 Italy
14.3.6 Spain
14.3.7 Turkey
14.3.8 Poland
14.3.9 Belgium
14.3.10 Netherlands
14.3.11 Switzerland
14.3.12 Denmark
14.3.13 Sweden
14.3.14 Norway
14.3.15 Finland
14.3.16 Rest Of Europe
List Of Tables
Table 1 Global Stroke Market, By Type, 2022-2030 (Usd Thousand)
Table 2 Global Ischemic Stroke In Stroke Market, By Region, 2021-2030 (Usd Thousand)
Table 3 Global Ischemic Stroke In Stroke Market, By Type, 2021-2030 (Usd Thousand)
Table 4 Global Hemorrhagic Stroke In Stroke Market, By Region, 2021-2030 (Usd Thousand)
Table 5 Global Hemorrhagic Stroke In Stroke Market, By Type, 2021-2030 (Usd Thousand)
Table 6 Global Transient Ischemic Attack (Tia) In Stroke Market, By Region, 2021-2030 (Usd Thousand)
Table 7 Global Stroke Market, By Treatment, 2021-2030 (Usd Thousand)
Table 8 Global Medication In Stroke Market, By Region, 2021-2030 (Usd Thousand)
Table 9 Global Medication In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 10 Global Blood Pressure Medicines In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 11 Global Angiotensin-converting Enzyme (Ace) Inhibitors In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 12 Global Diuretics In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 13 Global Calcium Channel Blockers In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 14 Global Beta Blockers In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 15 Global Alpha Blockers In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 16 Global Antiplatelet Drugs In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 17 Global Anticoagulants In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 18 Global Tissue Plasminogen Activator (Tpa) In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 19 Global Statins In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 20 Global Supportive Medication In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 21 Global Medication In Stroke Market, By Drug Type, 2021-2030 (Usd Thousand)
Table 22 Global Branded In Stroke Market, By Drug Type, 2021-2030 (Usd Thousand)
Table 23 Global Medication In Stroke Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 24 Global Oral In Stroke Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 25 Global Parenteral In Stroke Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 26 Global Medication In Stroke Market, By Mode Of Purchase, 2021-2030 (Usd Thousand)
Table 27 Global Medication In Stroke Market, By Therapy Type, 2021-2030 (Usd Thousand)
Table 28 Global Surgery In Stroke Market, By Region, 2021-2030 (Usd Thousand)
Table 29 Global Surgery In Stroke Market, By Treatment, 2021-2030 (Usd Thousand)
Table 30 Global Other Therapy In Stroke Market, By Region, 2021-2030 (Usd Thousand)
Table 31 Global Other Therapy In Stroke Market, By Treatment, 2021-2030 (Usd Thousand)
Table 32 Global Stroke Market, By Diagnosis, 2021-2030 (Usd Thousand)
Table 33 Global Imaging Test In Stroke Market, By Region, 2021-2030 (Usd Thousand)
Table 34 Global Imaging Test In Stroke Market, By Type, 2021-2030 (Usd Thousand)
Table 35 Global Blood Test In Stroke Market, By Region, 2021-2030 (Usd Thousand)
Table 36 Global Echocardiogram In Stroke Market, By Region, 2021-2030 (Usd Thousand)
Table 37 Global Lumbar Puncture In Stroke Market, By Region, 2021-2030 (Usd Thousand)
Table 38 Global Others In Stroke Market, By Region, 2021-2030 (Usd Thousand)
Table 39 Global Stroke Market, By Gender, 2021-2030 (Usd Thousand)
Table 40 Global Female In Stroke Market, By Region, 2021-2030 (Usd Thousand)
Table 41 Global Male In Stroke Market, By Region, 2021-2030 (Usd Thousand)
Table 42 Global Stroke Market, By End User, 2021-2030 (Usd Thousand)
Table 43 Global Hospitals & Clinics In Stroke Market, By Region, 2021-2030 (Usd Thousand)
Table 44 Global Specialty Clinics In Stroke Market, By Region, 2021-2030 (Usd Thousand)
Table 45 Global Ambulatory Surgical Center In Stroke Market, By Region, 2021-2030 (Usd Thousand)
Table 46 Global Homecare In Stroke Market, By Region, 2021-2030 (Usd Thousand)
Table 47 Global Laboratories In Stroke Market, By Region, 2021-2030 (Usd Thousand)
Table 48 Global Others In Stroke Market, By Region, 2021-2030 (Usd Thousand)
Table 49 Global Stroke Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 50 Global Direct In Stroke Market, By Region, 2021-2030 (Usd Thousand)
Table 51 Global Retail In Stroke Market, By Region, 2021-2030 (Usd Thousand)
Table 52 Global Online In Stroke Market, By Region, 2021-2030 (Usd Thousand)
Table 53 Global Stroke Market, By Region, 2021-2030 (Usd Thousand)
Table 54 North America Stroke Market, By Country, 2021-2030 (Usd Thousand)
Table 55 North America Stroke Market, By Type, 2021-2030 (Usd Thousand)
Table 56 North America Ischemic Stroke In Stroke Market, By Type, 2021-2030 (Usd Thousand)
Table 57 North America Hemorrhagic Stroke In Stroke Market, By Type, 2021-2030 (Usd Thousand)
Table 58 North America Stroke Market, By Diagnosis And Treatment, 2021-2030 (Usd Thousand)
Table 59 North America Stroke Market, By Treatment, 2021-2030 (Usd Thousand)
Table 60 North America Medication In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 61 North America Blood Pressure Medicine In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 62 North America Angiotensin-converting Enzyme (Ace) Inhibitors In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 63 North America Diuretics In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 64 North America Calcium Channel Blockers In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 65 North America Beta Blockers In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 66 North America Alpha-blockers In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 67 North America Antiplatelet Drugs In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 68 North America Anticoagulants In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 69 North America Tissue Plasminogen Activator (Tpa) In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 70 North America Statins In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 71 North America Supportive Medication In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 72 North America Medication In Stroke Market, By Drug Type, 2021-2030 (Usd Thousand)
Table 73 North America Branded In Stroke Market, By Drug Type, 2021-2030 (Usd Thousand)
Table 74 North America Medication In Stroke Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 75 North America Oral In Stroke Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 76 North America Parenteral In Stroke Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 77 North America Medication In Stroke Market, By Mode Of Purchase, 2021-2030 (Usd Thousand)
Table 78 North America Medication In Stroke Market, By Therapy Type, 2021-2030 (Usd Thousand)
Table 79 North America Surgery In Stroke Market, By Treatment, 2021-2030 (Usd Thousand)
Table 80 North America Other Therapy In Stroke Market, By Treatment, 2021-2030 (Usd Thousand)
Table 81 North America Stroke Market, By Diagnosis, 2021-2030 (Usd Thousand)
Table 82 North America Imaging Test In Stroke Market, By Type, 2021-2030 (Usd Thousand)
Table 83 North America Stroke Market, By Gender, 2021-2030 (Usd Thousand)
Table 84 North America Stroke Market, By End User, 2021-2030 (Usd Thousand)
Table 85 North America Stroke Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 86 U.S. Stroke Market, By Type, 2021-2030 (Usd Thousand)
Table 87 U.S. Ischemic Stroke In Stroke Market, By Type, 2021-2030 (Usd Thousand)
Table 88 U.S. Hemorrhagic Stroke In Stroke Market, By Type, 2021-2030 (Usd Thousand)
Table 89 U.S. Stroke Market, By Diagnosis And Treatment, 2021-2030 (Usd Thousand)
Table 90 U.S. Stroke Market, By Treatment, 2021-2030 (Usd Thousand)
Table 91 U.S. Medication In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 92 U.S. Blood Pressure Medicine In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 93 U.S. Angiotensin-converting Enzyme (Ace) Inhibitors In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 94 U.S. Diuretics In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 95 U.S. Calcium Channel Blockers In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 96 U.S. Beta Blockers In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 97 U.S. Alpha-blockers In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 98 U.S. Antiplatelet Drugs In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 99 U.S. Anticoagulants In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 100 U.S. Tissue Plasminogen Activator (Tpa) In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 101 U.S. Statins In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 102 U.S. Supportive Medication In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 103 U.S. Medication In Stroke Market, By Drug Type, 2021-2030 (Usd Thousand)
Table 104 U.S. Branded In Stroke Market, By Drug Type, 2021-2030 (Usd Thousand)
Table 105 U.S. Medication In Stroke Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 106 U.S. Oral In Stroke Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 107 U.S. Parenteral In Stroke Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 108 U.S. Medication In Stroke Market, By Mode Of Purchase, 2021-2030 (Usd Thousand)
Table 109 U.S. Medication In Stroke Market, By Therapy Type, 2021-2030 (Usd Thousand)
Table 110 U.S. Surgery In Stroke Market, By Treatment, 2021-2030 (Usd Thousand)
Table 111 U.S. Other Therapy In Stroke Market, By Treatment, 2021-2030 (Usd Thousand)
Table 112 U.S. Stroke Market, By Diagnosis, 2021-2030 (Usd Thousand)
Table 113 U.S. Imaging Test In Stroke Market, By Type, 2021-2030 (Usd Thousand)
Table 114 U.S. Stroke Market, By Gender, 2021-2030 (Usd Thousand)
Table 115 U.S. Stroke Market, By End User, 2021-2030 (Usd Thousand)
Table 116 U.S. Stroke Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 117 Canada Stroke Market, By Type, 2021-2030 (Usd Thousand)
Table 118 Canada Ischemic Stroke In Stroke Market, By Type, 2021-2030 (Usd Thousand)
Table 119 Canada Hemorrhagic Stroke In Stroke Market, By Type, 2021-2030 (Usd Thousand)
Table 120 Canada Stroke Market, By Diagnosis And Treatment, 2021-2030 (Usd Thousand)
Table 121 Canada Stroke Market, By Treatment, 2021-2030 (Usd Thousand)
Table 122 Canada Medication In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 123 Canada Blood Pressure Medicine In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 124 Canada Angiotensin-converting Enzyme (Ace) Inhibitors In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 125 Canada Diuretics In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 126 Canada Calcium Channel Blockers In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 127 Canada Beta Blockers In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 128 Canada Alpha-blockers In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 129 Canada Antiplatelet Drugs In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 130 Canada Anticoagulants In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 131 Canada Tissue Plasminogen Activator (Tpa) In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 132 Canada Statins In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 133 Canada Supportive Medication In Stroke Market, By Class, 2021-2030 (Usd Thousand)
Table 134 Canada Medication In Stroke Market, By Drug Type, 2021-2030 (Usd Thousand)
Table 135 Canada Branded In Stroke Market, By Drug Type, 2021-2030 (Usd Thousand)
Table 136 Canada Medication In Stroke Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 137 Canada Oral In Stroke Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 138 Canada Parenteral In Stroke Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 139 Canada Medication In Stroke Market, By Mode Of Purchase, 2021-2030 (Usd Thousand)
Table 140 Canada Medication In Stroke Market, By Therapy Type, 2021-2030 (Usd Thousand)
Table 141 Canada Surgery In Stroke Market, By Treatment, 2021-2030 (Usd Thousand)
Table 142 Canada Other Therapy In Stroke Market, By Treatment, 2021-2030 (Usd Thousand)
Table 143 Canada Stroke Market, By Diagnosis, 2021-2030 (Usd Thousand)
Table 144 Canada Imaging Test In Stroke Market, By Type, 2021-2030 (Usd Thousand)
Table 145 Canada Stroke Market, By Gender, 2021-2030 (Usd Thousand)
Table 146 Canada Stroke Market, By End User, 2021-2030 (Usd Thousand)
Table 147 Canada Stroke Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 148 Mexico Stroke Market, By Type, 2021-2030 (Usd Thousand)
Table 149 Mexico Ischemic Stroke In Stroke Market, By Type, 2021-2030 (Usd Thousand)
List Of Figures
Figure 1 Global Stroke Market: Segmentation
Figure 2 Global Stroke Market: Data Triangulation
Figure 3 Global Stroke Market: Droc Analysis
Figure 4 Global Stroke Market : Global Vs Regional Market Analysis
Figure 5 Global Stroke Market: Company Research Analysis
Figure 6 Global Stroke Market: Interview Demographics
Figure 7 Global Stroke Market: Dbmr Market Position Grid
Figure 8 Global Stroke Market: Market Application Coverage Grid
Figure 9 Global Stroke Market: Vendor Share Analysis
Figure 10 Global Stroke Market: Segmentation
Figure 11 Increasing Number Of Patients With Hypertension And Coronary Heart Disease Is Expected To Drive The Global Stroke Market Growth In The Forecast Period Of 2023 To 2030
Figure 12 Ischemic Stroke Segment Is Expected To Account For The Largest Share Of The Global Stroke Market In The Forecast Period Of 2023 & 2030
Figure 13 North Ameirca Is Expected To Dominate The Global Stroke Market, And Asia-pacific Is Expected To Grow With The Highest Cagr In The Forecast Period Of 2023 To 2030
Figure 14 Asia-pacific Is The Fastest-growing Market For Stroke Manufacturers In The Forecast Period Of 2023 To 2030
Figure 15 Drivers, Restraints, Opportunities, And Challenges Of The Global Stroke Market
Figure 16 Global Stroke Market: By Type, 2022
Figure 17 Global Stroke Market: By Type, 2023-2030 (Usd Thousand)
Figure 18 Global Stroke Market: By Type, Cagr (2023-2030)
Figure 19 Global Stroke Market: By Type, Lifeline Curve
Figure 20 Global Stroke Market: By Treatment, 2022
Figure 21 Global Stroke Market: By Treatment, 2023-2030 (Usd Million)
Figure 22 Global Stroke Market: By Treatment, Cagr (2023-2030)
Figure 23 Global Stroke Market: By Treatment, Lifeline Curve
Figure 24 Global Stroke Market: By Diagnosis, 2022
Figure 25 Global Stroke Market: By Diagnosis, 2023-2030 (Usd Thousand)
Figure 26 Global Stroke Market: By Diagnosis, Cagr (2023-2030)
Figure 27 Global Stroke Market: By Diagnosis, Lifeline Curve
Figure 28 Global Stroke Market: By Gender, 2022
Figure 29 Global Stroke Market: By Gender, 2023-2030 (Usd Thousand)
Figure 30 Global Stroke Market: By Gender, Cagr (2023-2030)
Figure 31 Global Stroke Market: By Gender, Lifeline Curve
Figure 32 Global Stroke Market: By End User, 2022
Figure 33 Global Stroke Market: By End User, 2023-2030 (Usd Thousand)
Figure 34 Global Stroke Market: By End User, Cagr (2023-2030)
Figure 35 Global Stroke Market: By End User, Lifeline Curve
Figure 36 Global Stroke Market: By Distribution Channel, 2022
Figure 37 Global Stroke Market: By Distribution Channel, 2023-2030 (Usd Thousand)
Figure 38 Global Stroke Market: By Distribution Channel, Cagr (2023-2030)
Figure 39 Global Stroke Market: By Distribution Channel, Lifeline Curve
Figure 40 Global Stroke Market: Snapshot (2022)
Figure 41 Global Stroke Market: Company Share 2022 (%)
Figure 42 North America Stroke Market: Company Share 2022 (%)
Figure 43 Europe Stroke Market: Company Share 2022 (%)
Figure 44 Asia-pacific Stroke Market: Company Share 2022 (%)

$4,800
$7,000

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings